ReviewMedical oncology (Northwood, London, England)2017

Trial-level analysis of progression-free survival and response rate as end points of trials of first-line chemotherapy in advanced ovarian cancer.

Giuseppe Colloca et al.PubMed ↗Publisher ↗

No numbers read from the abstract.